- This event has passed.
Expert-in-Residence One-on-One Meeting: Dennis Berman
October 27, 2016 @ 10:00 am - 4:00 pm
Dennis Berman has been co-founder and/or seed investor in six companies, all of which went public, achieving a combined value over $7 billion. The most well known of these was Intervu Inc, one of the first software as a service companies which delivered 50% of all online video traffic when it was acquired by Akamai in 2000. Other companies Dennis was involved with include two life sciences groups, Gensia Pharmaceuticals and Viagene, and Kintera, a pioneer in Internet fundraising. Dennis is co-founder and Executive Vice President Corporate Development of Tocagen Inc., a gene therapy company developing treatments for cancer patients.
Dennis holds a B.A. from the University of Pennsylvania in Economics and a B.S. from The Wharton School in Accounting and Economics. He also holds a General Course Certificate from the London School of Economics and received his JD from Harvard Law School.
Industry Knowledge: Medical industry, Life and health sciences, Venture capital, Computer services.
About the Expert-in-Residence Series
For students from the law school and beyond who are interested in entrepreneurship, we invite you to take this opportunity to meet with one (or more!) of the law school’s Experts-in-Residence. With a diverse range of backgrounds and expertise, the EiRs have volunteered their time to help students succeed in entrepreneurial ventures with career and business advice drawn from their years of experience.